Speaker Profile
Market Access Strategy Director, Roche
Biography
Dawn Cardeiro, M.S., is a Market Access Strategy Director at Roche Diagnostics, where she develops U.S. strategies to advance patient access to innovative diagnostics. Her career spans over three decades in clinical, advocacy, and commercial roles in precision medicine, including positions at North Central Bronx Hospital, Baystate Medical Center, Point32Health, Myriad Genetics, and Foundation Medicine.
Dedicated to shaping payer policy and expanding access to diagnostics, Dawn serves on the board of the Access to Comprehensive Genomic Profiling Coalition (ACGP) and previously served on the board of directors for the Personalized Medicine Coalition (PMC).
She holds a B.S. in Chemistry from Fairfield University and an M.S. in Human Genetics from Sarah Lawrence College, where she trained as a genetic counselor. By combining her clinical roots and deep technical foundation with extensive industry expertise, Dawn effectively navigates complex health systems to improve patient outcomes.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Christina Curtis, Stanford
PMWC Award Ceremony
• Joe DeRisi, UCSF / CZ Biohub / Delve Bio (Luminary)
• Alexandre Loupy, Inserm / Paris Transplant Group (Pioneer)
Featured Speakers
• Joe DeRisi, UCSF / CZ Biohub / Delve Bio
• Alexandre Loupy, Inserm / Paris Transplant Group
• Minnie Sarwal, UCSF
• Kiran Khush, Stanford
• Iwijn De Vlaminck, Cornell
• Maarten Naesens, KU Leuven
• Charles Chiu, UCSF
• Michael Snyder, Stanford
• Duncan MacCannell, CDC
• Chaz Langelier, UCSF
• Yoel Sadovsky, Stanford
• Ananth Karumanchi, Cedars-Sinai
• Gabriel Bien-Willner, Palmetto GBA / MolDX
• Dawn Cardeiro, Roche Diagnostics
• Bruce Quinn, Bruce Quinn Associates
Transplant & Organ Health Diagnostics
From biopsy to blood-based monitoring of rejection, injury, and infection.
Blood-Based Omics and Host Response in Infection
Metagenomics and host-response signals for difficult infectious disease cases.
Maternal & Fetal Health
From prenatal screening to actionable maternal and placental biomarkers.
From Signal to Standard of Care
What makes a non-cancer blood test clinically actionable and reimbursable.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
